HEMOLYTIC-ANEMIA FOLLOWING SUCCIMER ADMINISTRATION IN A GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENT PATIENT

被引：12

作者：

GERR, F ^{[1
]}

FRUMKIN, H ^{[1
]}

HODGINS, P ^{[1
]}

机构：

[1] EMORY CLIN,ATLANTA,GA

来源：

JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 1994年 / 32卷 / 05期

关键词：

DIMERCAPTOSUCCINIC ACID; HEMOLYTIC ANEMIA; LEAD TOXICITY; HUMAN;

D O I：

10.3109/15563659409011061

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

Because of its favorable side effects profile, the oral chelating agent dimercaptosuccinic acid is often used for treatment of lead intoxication. We report a case of a 45-year-old black male with glucose-6-phosphate dehydrogenase deficiency and a 17 year history of occupational lead exposure who developed hemolysis during treatment with dimercaptosuccinic acid for symptomatic lead intoxication.

引用

页码：569 / 575

页数：7

共 24 条

[21] LEAD-EXPOSURE AMONG LEAD-ACID-BATTERY WORKERS IN JAMAICA
MATTE, TD
FIGUEROA, JP
BURR, G
FLESCH, JP
KEENLYSIDE, RA
BAKER, EL
[J]. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1989, 16 (02) : 167 - 177
[22] CORRECTION
NIGHTINGALE, SL
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14): : 1802 - 1802
[23] TRENDS IN RACIAL-INEQUALITY AND EXPOSURE TO WORK-RELATED HAZARDS, 1968-1986
ROBINSON, JC
[J]. MILBANK QUARTERLY, 1987, 65 : 404 - 420
[24] HEMOLYTIC-ANEMIAS AND ERYTHROCYTE ENZYMOPATHIES
VALENTINE, WN
TANAKA, KR
PAGLIA, DE
[J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (02) : 245 - 257

← 1 2 3 →